Gender difference in glyoxalase 1 activity of atherosclerotic carotid artery lesions

Journal of Vascular Surgery

Volumn 62, Issue 2, 2015, Pages 471-476

  Peters, Andreas S ^a   Hakimi, Maani ^a   Vittas, Spiros ^a   Fleming, Thomas H ^a   Nawroth, Peter P ^a   Böckler, Dittmar ^a   Dihlmann, Susanne ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYOXALASE; GLYOXALASE 1; INTERLEUKIN 1BETA; PROTEIN; UNCLASSIFIED DRUG; GLO1 PROTEIN, HUMAN; LACTOYLGLUTATHIONE LYASE;

ADULT; AGED; ARTICLE; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DETOXIFICATION; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SEX DIFFERENCE; TISSUE SECTION; BIOSYNTHESIS; CAROTID ARTERY; METABOLISM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CAROTID ARTERIES; CAROTID ARTERY DISEASES; FEMALE; HUMANS; INTERLEUKIN-1BETA; LACTOYLGLUTATHIONE LYASE; MALE; MIDDLE AGED; SEX FACTORS;

EID: 84937811850     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2014.02.058     Document Type: Article

References (20)

1. R.C. Thompson, A.H. Allam, G.P. Lombardi, L.S. Wann, M.L. Sutherland, J.D. Sutherland, and et al. Atherosclerosis across 4000 years of human history: the Horus study of four ancient populations Lancet 381 2013 1211 1222
2. M. Morcos, X. Du, F. Pfisterer, H. Hutter, A.A. Sayed, P. Thornalley, and et al. Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans Aging Cell 7 2008 260 269
3. T.H. Fleming, T.M. Theilen, J. Masania, M. Wunderle, J. Karimi, S. Vittas, and et al. Aging-dependent reduction in glyoxalase 1 delays wound healing Gerontology 59 2013 427 437
4. J.E. Kirk The glyoxalase I activity of arterial tissue in individuals of various ages J Gerontol 15 1960 139 141
5. L. Engelen, I. Ferreira, O. Brouwers, R.M. Henry, J.M. Dekker, G. Nijpels, and et al. Polymorphisms in glyoxalase 1 gene are not associated with vascular complications: the Hoorn and CoDAM studies J Hypertens 27 2009 1399 1403
6. J.C. Wu, X.H. Li, J.B. Wang, J.F. Tang, Y.F. Wang, and Y.D. Peng Glyoxalase I and aldose reductase gene polymorphisms and susceptibility to carotid atherosclerosis in type 2 diabetes Genet Test Mol Biomarkers 15 2011 273 279
7. L. Wu, and B.H. Juurlink Increased methylglyoxal and oxidative stress in hypertensive rat vascular smooth muscle cells Hypertension 39 2002 809 814
8. N.M. Hanssen, K. Wouters, M.S. Huijberts, M.J. Gijbels, J.C. Sluimer, J.L. Scheijen, and et al. Higher levels of advanced glycation endproducts in human carotid atherosclerotic plaques are associated with a rupture-prone phenotype Eur Heart J 35 2014 1137 1146
9. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
10. M. Hakimi, A. Peters, A. Becker, D. Bockler, and S. Dihlmann Inflammation-related induction of absent in melanoma 2 (AIM2) in vascular cells and atherosclerotic lesions suggests a role in vascular pathogenesis J Vasc Surg 59 2014 794 803.e23
11. T. Strowig, J. Henao-Mejia, E. Elinav, and R. Flavell Inflammasomes in health and disease Nature 481 2001 278 286
12. A. Qamar, and D.J. Rader Effect of interleukin 1beta inhibition in cardiovascular disease Curr Opin Lipidol 23 2012 548 553
13. S. Tsimikas, G.W. Duff, P.B. Berger, J. Rogus, K. Huttner, P. Clopton, and et al. Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a) J Am Coll Cardiol 63 2014 1724 1734
14. J. Galea, J. Armstrong, P. Gadsdon, H. Holden, S.E. Francis, and C.M. Holt Interleukin-1 beta in coronary arteries of patients with ischemic heart disease Arterioscler Thromb Vasc Biol 16 1996 1000 1006
15. G. Birkenmeier, C. Stegemann, R. Hoffmann, R. Gunther, K. Huse, and C. Birkemeyer Posttranslational modification of human glyoxalase 1 indicates redox-dependent regulation PLoS One 5 2010 e10399
16. F. Van Herreweghe, J. Mao, F.W. Chaplen, J. Grooten, K. Gevaert, J. Vandekerckhove, and et al. Tumor necrosis factor-induced modulation of glyoxalase I activities through phosphorylation by PKA results in cell death and is accompanied by the formation of a specific methylglyoxal-derived AGE Proc Natl Acad Sci U S A 99 2002 949 954
17. V. de Hemptinne, D. Rondas, M. Toepoel, and K. Vancompernolle Phosphorylation on Thr-106 and NO-modification of glyoxalase I suppress the TNF-induced transcriptional activity of NF-kappaB Mol Cell Biochem 325 2009 169 178
18. A. Mitsumoto, K.R. Kim, G. Oshima, M. Kunimoto, K. Okawa, A. Iwamatsu, and et al. Glyoxalase I is a novel nitric-oxide-responsive protein Biochem J 344 1999 837 844
19. A. Mitsumoto, K.R. Kim, G. Oshima, M. Kunimoto, K. Okawa, A. Iwamatsu, and et al. Nitric oxide inactivates glyoxalase I in cooperation with glutathione J Biochem 128 2000 647 654
20. M. Xue, N. Rabbani, and P.J. Thornalley Glyoxalase in ageing Semin Cell Dev Biol 22 2011 293 301